Medicinal product name Medrol 4 mg tablets
Pharmaceutical form Tablet
Strength 4 mg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
99-1042-02 KZSRN100 Is available
Legal status Rx Prescription (Pr.)
KZSR Reimbursed medicines reference product
Package leaflet MS Word document 14-11-2019
Summary of product characteristics MS Word document 05-12-2019
ATC code H02AB04 Corticosteroids for systemic use

Important notice

Additional information regarding the use for persons aged 75+

If used as "CORTICOSTEROIDS FOR SYSTEMIC USE"
SubstanceClassComment
MethylprednisolonumCSuitable for older persons, with specific cautions. Adverse effects are emphasised in long-term use. Take interactions into account.

Medicinal products (4)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers)
predicted availability date: not notified
currently no information on availability from any wholesaler N30
(4 mg)
PVC/Al blister    99-1042-01 Labelling text Labelling text Aug 9, 2018
 Is available (according to the information provided by wholesalers)
(691 containers)
Tamro, Olainfarm, Recipe Plus, Oribalt Rīga, Magnum Medical, Medelens+ N100
(4 mg)
PVC/Al blister 10.34 
KZSR*
99-1042-02 Labelling text Labelling text Aug 9, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N30
(4 mg)
HDPE bottle    99-1042-05 Labelling text Labelling text Aug 9, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N100
(4 mg)
HDPE bottle    99-1042-06 Labelling text Labelling text Aug 9, 2018
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. 99-1042
Date of authorisation Dec 28, 1999
MA valid until For unlimited time
Marketing authorisation holder, country Pfizer Europe MA EEIG, Belgium